跳至主要内容
临床试验/ACTRN12619001705178
ACTRN12619001705178终止4 期

Intravenous Cefazolin v Placebo for pre-incision prophylaxis in very low-risk women undergoing elective caesarean section: RCT Pilot Feasibility Study.

Royal Brisbane and Women's Hospital0 个研究点目标入组 30 人开始时间: 2019年12月4日最近更新:
适应症

试验速览

阶段
4 期
状态
终止
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 39 Years(—)
性别
Female

入选标准

  • Scheduled for elective caesarean section. Age < 40 years and greater than or equal to 18 years, gestation greater than 37 weeks, membranes intact, body mass index less than 25, not in labour, non-smoking, haemoglobin greater than 110g/L, non-diabetic, (Type 1, Type 2 or gestational diabetes) American Society of Anesthesiologists score (ASA score) = 2. (The ASA score is classification of physical status: 1 being a healthy patient, 5 being a moribund patient and 6 being an organ donor. Pregnancy is classified as a minimum score of 2.)

排除标准

  • Allergy to cephalosporin antibiotics, allergy to chlorhexidine, conditions pre-disposing to haemorrhage (anticoagulation, thrombocytopaenia, abnormal placentation) conditions pre-disposing to infection (immunosuppression, autoimmune disorders, steroid use), complex cardiac or respiratory disease, classical uterine incision (vertical), use of a wound drain, manual removal of placenta.

研究者

相似试验